Appendix 1
Claims
The CaMv promoters: 35S and 19S
Plant Ubiquitin Promoter System
Maize alcohol dehydrogenase 1 (Adh-1) promoter
Opine Promoters
1. Promoters and UAS from opine synthase genes
Patents granted to Biotechnology Research And Development Corporation & Purdue Research Foundation
Actual granted independent claims
|
Claim 1
a) a promoter derived from a mannopine synthase gene of Agrobacterium
tumefaciens, |
|
Claim 2
a) linking said foreign gene to a regulatory region comprising a promoter
derived from a mannopine synthase gene of Agrobacterium tumefaciens
comprising 138 bases upstream of the transcription initiation site, and an
upstream activating sequence derived from a mannopine synthase gene of
Agrobacterium tumefaciens; |
|
Claim 3
a) linking said foreign gene to a regulatory region comprising: i) a promoter derived from a mannopine synthase gene of Agrobacterium
tumefaciens, b) inserting said foreign gene and said regulatory region in said plant, wherein expression is induced by nematode attack on the plant. |
|
Claim 4
|
|
Claim 5
|
|
Claim 6
|
|
Claim 7
a) linking said foreign gene to a chimeric regulatory region comprising at
least three upstream activating sequences derived from an Agrobacterium
tumefaciens octopine synthase gene operably linked to a promoter derived
from an Agrobacterium tumefaciens mannopine synthase gene; and |
|
Claim 8
|
|
Claim 9
|
|
Claim 10
|
|
Claim 11
a) linking said foreign gene to a chimeric regulatory region comprising at
least three upstream activating sequences derived from an Agrobacterium
tumefaciens octopine synthase gene operably linked to an upstream
activating sequence derived from an Agrobacterium tumefaciens
mannopine synthase gene that is operably linked to a promoter derived from an
Agrobacterium tumefaciens mannopine synthase gene; and |
|
Claim 12
|
| AU 687961 B |
|---|
|
Claim 1
|
|
Claim 2
|
|
Claim 4
|
|
Claim 8
|
|
Claim 13
a) a promoter derived from a mannopine synthase gene of Agrobacterium
tumefaciens by deletion to nucleotide position -138, and |
|
Claim 15
a) a promoter derived from a mannopine synthase gene of Agrobacterium
tumefaciens, |
|
Claim 16
a) linking said gene to a chimeric regulatory region comprising an upstream
activating sequence derived from an Agrobacterium tumefaciens octopine
synthase gene operably linked to a promoter derived from an Agrobacterium
tumefaciens mannopine synthase gene; |
|
Claim 17
a) linking said gene to a chimeric regulatory region comprising at least two
upstream activating sequences derived from an Agrobacterium tumefaciens
opine synthase gene operably linked to a promoter derived from an
Agrobacterium tumefaciens opine synthase gene, wherein at least one of
said upstream activating elements are derived from a different opine synthase
gene than said promoter; |
|
Claim 21
a) linking said foreign gene to a regulatory region comprising: i. a promoter derived from a mannopine synthase gene of Agrobacterium tumefaciens by deletion to nucleotide position -138, and ii. an upstream activating sequence derived from a mannopine synthase gene of Agrobacterium tumefaciens; b) inserting said foreign gene and said regulatory region in said plant; and
|
|
Claim 23
a) linking said foreign gene to a regulatory region comprising: i. a promoter derived from a mannopine synthase gene of Agrobacterium tumefaciens, ii. an upstream activating sequence derived from a mannopine synthase gene of Agrobacterium tumefaciens; and iii. an upstream activating sequence derived from an octopine synthase gene of Agrobacterium tumefaciens; b) inserting said foreign gene and said regulatory region in said plant; and
|
|
Claim 32
|
|
Claim 33
|
|
Claim 34
a) linking said gene to a chimeric regulatory region comprising at least
three upstream activating sequences derived from an Agrobacterium
tumefaciens octopine synthase gene operably linked to a promoter derived
from an Agrobacterium tumefaciens mannopine synthase; |
|
Claim 37
|
|
Claim 39
|
|
Claim 40
|
|
Claim 41
|
Patent applications filed by Biotechnology Research and Development Corporation & Purdue Research Foundation
Actual pending independent claims
| EP 729514 A1 |
|---|
|
Claim 1
|
|
Claim 4
|
|
Claim 8
|
|
Claim 12
|
|
Claim 17
|
|
Claim 19
|
|
Claim 20
|
|
Claim 23
|
|
Claim 27
|
|
Claim 29
|
| CA 2174954 |
|---|
|
Claim 1
|
|
Claim 2
|
|
Claim 4
|
|
Claim 8
|
|
Claim 13
|
|
Claim 15
|
|
Claim 16
|
|
Claim 17
|
|
Claim 21
|
|
Claim 23
|
|
Claim 32
|
|
Claim 33
|
|
Claim 34
|
The CaMV promoters: 35S and 19S
Actual granted independent claims
Patents granted to Monsanto
|
Claim 1
(i) a promoter from a cauliflower mosaic virus, said promoter selected from
the group consisting of a CaMV (35S) promoter isolated from CaMV
protein-encoding DNA sequences and a CaMV (19S) promoter isolated from CaMV
protein-encoding DNA sequences, and |
|
Claim 4
(i) a promoter from cauliflower mosaic virus, said promoter selected from the
group consisting of a CaMV (35S) promoter and a CaMV (19S) promoter, wherein
said promoter is isolated from CaMV protein-encoding DNA sequences, and |
|
Claim 7
(i) a region of homology to an Agrobacterium tumefaciens vector,
said chimeric gene comprising: (i) a promoter from cauliflower mosaic virus, said promoter selected from the
group consisting of a CaMV(35S) promoter and a CaMV(19S) promoter, and |
|
Claim 8
(i) a disarmed plant tumor inducing plasmid of Agrobacterium tume
faciens and |
|
Claim 13
(i) a CaMV promoter selected from the group consisting of (a) a CaMV 35S promoter isolated from CaMV protein-encoding DNA sequences and
(ii) a DNA sequence of interest heterologous to (i), wherein (ii) is under the regulatory control of (i) when said construct is transcribed in a plant cell. |
|
Claim 14
(i) a promoter from cauliflower mosaic virus, said promoter selected from the group consisting of: (a) a CaMV 35S promoter region free of CaMV protein-encoding DNA sequences
and (ii) a DNA sequence which is heterologous with respect to the promoter. |
|
Claim 15
(i) a promoter from a cauliflower mosaic virus, said promoter selected from the group consisting of (a) a CaMV(35S) promoter region free of CaMV protein-encoding DNA sequences
and (ii) a DNA sequence which is heterologous with respect to the promoter. |
|
Claim 16
(i) a promoter from a cauliflower mosaic virus, said promoter selected from the group consisting of (a) a CaMV(35S) promoter free of CaMV protein-encoding DNA sequences and
(ii) a DNA sequence which is heterologous with respect to the promoter and
|
|
Claim 17
(i) a promoter from cauliflower mosaic virus, said promoter selected from the
group consisting of |
Patents on entire 35S and 19S promoters granted to Monsanto
Actual granted independent claims
|
Claim 1
a) a promoter from cauliflower mosaic virus, said promoter selected from the group consisting of
b) a structural sequence which is heterologous with respect to the promoter. |
|
Claim 4
|
|
Claim 5
i. a promoter from cauliflower mosaic virus, said promoter selected from the group consisting of a CaMV(35S) promoter and a CaMV(19S) promoter, and ii. a DNA sequence which is heterologous with respect to the promoter. |
|
Claim 1
a) a promoter isolated from cauliflower mosaic virus (CaMV), said promoter selected from the group consisting of
b) a DNA sequence which is heterologous with respect to the promoter; |
|
Claim 1
a) a promoter from cauliflower mosaic virus (CaMV), wherein said promoter is
the CaMV(19S) promoter or the CaMV(35S) promoter, operably linked to
|
|
Claim 3
a) a promoter from cauliflower mosaic virus (CaMV), wherein said promoter is
the CaMV(19S) promoter or the CaMV(35S) promoter, operably linked to
|
|
Claim 6
a) a region of homology to an A. tumefaciens vector; wherein the chimeric gene is located between the T-DNA border and the region of homology, said chimeric gene comprising a promoter from cauliflower mosaic virus (CaMV), wherein said promoter is the CaMV(19S) promoter or the CaMV(35S) promoter, operably linked to a DNA sequence which is heterologous with respect to the promoter, wherein: a) the promoter regulates the transcription of the DNA sequence, and |
|
Claim 9
a) the promoter regulates the transcription of the DNA sequence, and |
|
Claim 12
a) the promoter regulates the transcription of the DNA sequence, and |
|
Claim 1
a) a promoter region from a ribulose-1,5-bis-phosphate carboxylase small subunit gene; b) a 5' non-translated region; c)a structural coding sequence encoding neomycin phosphotransferase I oy II; and d) a 3' non-translated region of a gene naturally expressed in plant cells, said region encoding a signal sequence for polyadnylation of mRNA; said promoter being heterologous with respect to the structural coding sequence.
Claim 4
a) a full-length transcript promoter region isolated from cauliflower mosaic
virus |
Patents granted to the Rockefeller University
Actual granted independent claims
|
Claim 1
*sequence of subdomain B2 of 35S CaMV promoter. |
|
Claim 2
*sequence of subdomain B2 of 35S CaMV promoter. |
|
Claim 3
*sequence of subdomain B3 of 35S CaMV promoter. |
|
Claim 4
*sequence of subdomain B4 of 35S CaMV promoter. |
|
Claim 5
*sequence of subdomain B5 of 35S CaMV 35S promoter. |
|
Claim 6
*sequence of subdomain B3 of 35S CaMV promoter. |
|
Claim 7
*sequence of subdomain B4 of 35S CaMV promoter. |
|
Claim 8
*sequence of subdomain B5 of 35S CaMV promoter. |
|
Claim 9
*sequence of subdomain B2 of 35S CaMV promoter. |
|
Claim 10
*sequence of subdomain B3 of CaMV 35S promoter |
|
Claim 11
*sequence of subdomain B4 of 35S CaMV promoter |
|
Claim 12
*sequence of subdomain B5 of 35S CaMV promoter |
Patent granted to the Rockefeller University
Actual granted independent claims
|
Claim 1
5'-TGAGACTTTT CAACAAAGGG TAATATCCGG AAACCTCCTC GGATTCCATT GCCCAGCTAT
CTGTCACTTT *sequence corresponds to the complete domain B -from -343 to -90 nucleotides- of the 35S CaMV promoter |
|
Claim 2
5'-TGAGACTTTT CAACAAAGGG TAATATCCGG AAACCTCCTC GGATTCCATT GCCCAGCTAT
CTGTCACTTT operably coupled directly to the -72 to +8 promoter fragment of the CaMV 35S gene, said -72 to +8 promoter fragment operably coupled to a structural gene. *sequence corresponds to the complete domain B from -343 to -90 nucleotides of the 35S CaMV promoter. |
|
Claim 5
5'-TGAGACTTTT CAACAAAGGG TAATATCCGG AAACCTCCTC GGATTCCATT GCCCAGCTAT
CTGTCACTTT *sequence corresponds to the complete domain B -from -343 to -90 nucleotides- of the 35S CaMV promoter. |
Plant Ubiquitin Promoter System
Patent application filed by Monsanto
Actual pending independent claims
| EP 1210446 |
|---|
|
Claim 1
|
|
Claim 2
|
Patents granted to Mycogen
Actual granted independent claims
|
Claim 1
a) two heat shock elements, which overlap; |
|
Claim 1
a) transforming said plant cell with a DNA construct comprising an approximately 2 kb plant ubiquitin regulatory region operably joined to a DNA sequence of interest, wherein said plant ubiquitin regulatory region is from a plant ubiquitin gene and comprises:
b) selectively applying stress conditions of high temperature to said transformed plant cell thereby inducing enhancement in expression of said DNA sequence of interest. |
|
Claim 1
a) a DNA sequence no larger than 2 kb, said DNA sequence comprising a plant ubiquitin regulatory system, wherein said regulatory system contains:
b) a plant-expressible structural gene wherein said structural gene is placed under the regulatory control of said plant ubiquitin regulatory system. |
|
Claim 1
a) a promoter comprising a transcription start site, |
|
Claim 9
a) a DNA fragment of approximately 2 kb in length, said DNA fragment comprising a plant ubiquitin regulatory system, wherein said plant ubiquitin regulatory system contains:
b) a plant-expressible heterologous structural gene positioned 3' to said
plant ubiquitin regulatory system and |
|
Claim 18
(a) one or more heat shock elements, which elements may or may not be
overlapping; wherein said DNA is isolated or incorporated into a larger piece of DNA but in a position other than in the 5' sequence of a plant ubiquitin gene, meaning of this?? Does not regulate the plant ubiquitin gene, is it that? or is not related to the 5'sequence of a plant ubiquitin gene at all?? |
| CA 1339684 |
|---|
|
Claim 1
|
|
Claim 11
b) a plant-expressible heterologous structural gene wherein said heterologous structural gene is placed under the regulatory control of said plant ubiquitin regulatory system. |
|
Claim 23
|
|
Claim 1
a) a heat shock element and |
|
Claim 10
a) a DNA sequence no larger than 2 kb, said DNA sequence comprising a plant ubiquitin regulatory system, wherein said regulatory system contains:
b) a plant-expressible structural gene wherein said structural gene is placed under the regulatory control of said plant ubiquitin regulatory system. |
|
Claim 12
a) transforming said plant cell with a DNA construct comprising: i. a plant ubiquitin regulatory system, wherein is found a heat shock element and an intron, and ii. a plant-expressible structural gene that is under the regulatory control of said plant ubiquitin regulatory system, and b) selectively applying stress conditions to said transformed plant cell thereby inducing enhancement in expression of said structural gene. |
Maize alcohol dehydrogenase 1 (Adh-1) promoter
1. Patents on the ARE of maize ADH and maize aldolase promoters
Actual granted independent claims
Patent granted to Lubrizol Enterprises and CSIRO
| CA 1338858 |
|---|
|
Claim 1
|
|
Claim 25
a) constructing a recombinant DNA molecule which comprises i. an anaerobic regulatory control element; ii. a plant-expressible promoter located 3' to said anaerobic regulatory element, and iii. a plant expressible structural gene located 3' to said plant express ible promoter such that said structural gene is placed under the regulatory control of said promoter and said anaerobic regulatory element; b) transforming said plant tissue with said recombinant DNA molecule, and
|
Patent granted to Mycogen Plant Science Inc. and CSIRO
|
Claim 1
|
Patent granted to Mycogen Plant Science Inc. and Lubrizol Enterprises
|
Claim 1
|
2. Patents on the recombinant promoter EMU
Patent granted to Lubrizol Genetics Inc.
| AU 643521 B2 |
|---|
|
Claim 1
a) a plurality of enhancer elements selected from the group consisting of the
ARE and the OCS elements; |
Patent granted to Mycogen Plant Science Inc. and CSIRO
|
Claim 1
a) a plurality of ARE enhancer elements; |
Patent granted to CSIRO
|
Claim 1
a) a plurality of enhancer elements selected from the group consisting of
only ARE elements, only OCS elements, and combinations of ARE and OCS elements;
|
Synthetic promoters
Patents granted to Pioneer Hi-Bred International Inc.
Actual granted independent claims
|
Claim 1
a TATA motif, |
|
Claim 2
a TATA motif, |
|
Claim 3
a synthetic promoter comprising: |
|
Claim 4
a synthetic promoter comprising: |
|
Claim 5
a synthetic promoter comprising: |
|
Claim 7
|
|
Claim 8
a promoter sequence; |
|
Claim 13
|
|
Claim 14
|
|
Claim 15
a core promoter sequence, |
|
Claim 1
a TATA motif, |
|
Claim 3
a synthetic promoter comprising |
|
Claim 17
|
|
Claim 18
|
|
Claim 23
a TATA motif, |
| EP 1056875 A1 |
|---|
|
Claim 1
a TATA motif ; |
|
Claim 4
a synthetic promoter comprising: |
|
Claim 19
|
|
Claim 20
a promoter sequence; |
|
Claim 25
a promoter construct, said construct comprising in operable linkage: |
|
Claim 32
a core synthetic promoter sequence comprising a TATA motif, |
|
Claim 38
|
|
Claim 40
a promoter construct, said construct comprising in operable linkage: |
|
Claim 46
a core promoter sequence; |
| CA 2257719 AA |
|---|
|
Claim 1
a TATA motif; |
|
Claim 4
a synthetic promoter comprising: |
|
Claim 19
|
|
Claim 20
a promoter sequence; |
|
Claim 25
a TATA motif; |
|
Claim 26
a TATA motif; |
|
US 2001/0047092 A1 and WO 01/53476 A2 |
|---|
|
Claim 1
a) a nucleotide sequence comprising six DRE 1 (SEQ ID NO.: 59), two ABRE1
(SEQ ID NO.: 2), three As-1 (SEQ ID NO.: 7), one GT-2 (SEQ ID NO.: 24), and two
PCNA IIA (SEQ ID NO.: 45) promoter elements; |
|
Claim 7
|
|
Claim 8
a) a nucleotide sequence comprising promoter elements DRE1, ABRE1, DRE1,
As-1, ABRE1, DRE1, GT-2, As-1, DRE1, PCNA IIA, PCNA IIA, DRE1, As-1, and DRE1
sequentially (SEQ ID NO.: 66); |
|
Claim 12
a) a nucleotide sequence comprising promoter elements DRE1, ABRE1, DRE1,
As-1, ABRE1, DRE1, GT-2, As-1, DRE1, PCNA IIA, PCNA IIA, DRE1, As-1, and DRE1
sequentially (SEQ ID NO.: 66); |
|
Claim 17
a) isolating or synthesizing oligonucleotides representing known or putative
promoter elements or transcription factor binding sites; |
|
Claim 18
a) selecting known or putative promoter elements or transcription factor
binding sites which exhibit preferential binding to nuclear extract prepared
from said tissue of interest; |
The information contained in this page was believed to be correct at the time it was collated. New patents and patent applications, altered status of patents, and case law may have resulted in changes in the landscape. CAMBIA makes no warranty that it is correct or up to date at this time and accepts no liability for any use that might be made of it. Corrections or updates to the information are welcome. Please send an email to info@bios.net.



There are no comments.